Consolidated Balance Sheets - USD ($)	Dec. 31, 2024	Dec. 31, 2023
Current assets:
Cash and cash equivalents	$ 8,999,496	$ 7,792,846
Marketable securities	29,922,523	0
Prepaid expenses and other current assets	1,905,360	1,256,501
Grant receivable	2,254,231	915,404
Total current assets	43,081,610	9,964,751
Other assets	0	7,770
Total assets	43,081,610	9,972,521
Current liabilities:
Accounts payable	1,511,440	662,471
Accrued expenses and other current liabilities	2,367,842	1,933,276
Total liabilities	3,879,282	2,595,747
Commitments and Contingencies
Stockholders’ Equity:
Common stock, $0.001 par value: 1,000,000,000 shares authorized: 8,702,719 and 5,674,520 shares issued and outstanding at December 31, 2024 and December 31, 2023, respectively	8,702	5,674
Additional paid-in capital	109,868,913	61,811,889
Accumulated other comprehensive income	56,197	0
Accumulated deficit	(70,731,484)	(54,440,789)
Total stockholders' equity	39,202,328	7,376,774
Total liabilities and stockholders' equity	43,081,610	9,972,521
Series Preferred Stock [Member]
Stockholders’ Equity:
Convertible preferred stock	$ 0	$ 0